Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Pemetrexed and Temozolomide in Treating Patients With Relapsed Primary Central Nervous System Lymphoma (PCNSL)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01985451
Recruitment Status : Unknown
Verified November 2013 by Rongjie Tao, Shandong Cancer Hospital and Institute.
Recruitment status was:  Active, not recruiting
First Posted : November 15, 2013
Last Update Posted : November 15, 2013
Sponsor:
Collaborator:
National Natural Science Foundation of China
Information provided by (Responsible Party):
Rongjie Tao, Shandong Cancer Hospital and Institute